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paper about the use of magnesium sulphate to reduce the shivering threshold. We question whether there is any potential 'real world' use for this proposed therapy of high-dose magnesium in patients with myocardial ischaemia, either peri-infarction, periangioplasty or perioperative coronary bypass graft surgery.
We agree that shivering is undesirable due to the increased oxygen consumption and can increase the risk of myocardial ischaemia. However, putting such a frail population, who are already in a compromised cardiovascular state, at the perils of high-dose magnesium infusion seems in contradiction to their best interests.
Magnesium can cause heart block, the risk being higher in patients who are already on calcium or beta receptor antagonists.
2 Treatment with magnesium by continuous infusion can cause severe muscle weakness. This effect is significant when serum levels >2 mg litre À1 , especially patients who are in renal failure. Specifically in the postoperative cardiac surgery population, there are other detrimental effects such as profound recurarization in patients who were treated with magnesium sulphate even at lower doses (60 mg kg À1 ) after 1 h of recovery of vecuronium block.
3 Magnesium can also increase the incidence of postsurgical bleeding by inhibition of platelet function and antagonizing calcium function on the clotting cascade. We use magnesium, given as a single 2-5 g slow i.v. infusion to reduce cardiac irritability after cardiac surgery in most of our patients. In a recent prospective audit of 110 postoperative cardiac surgery patients, we found 25% of postoperative patients were shivering with a mean core temperature of 36.3 (range 34.6-38 C), despite sedation with morphine and low dose propofol. We treat shivering patients with meperidine, and warm them appropriately as required. However, we are describing a population that is routinely mechanically ventilated after operation.
Maintaining magnesium levels at twice the normal level may not cause any detrimental effects in young, healthy volunteers. However, in sick patients the use of high-dose magnesium for the prevention of shivering is not practical. We wish the authors all the best with future research, which we suspect may be focused more on the patient at risk of cerebral ischaemia, rather than myocardial ischaemia.
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Editor-We would like to thank Drs Thanthulage and Stacey for their interest in our work. It is true that a relatively high, although not supra-clinical, dose of magnesium sulphate was used in our trial, which included young healthy volunteers.
1 However, the purpose of this study was not to 'propose a high-dose magnesium therapy in patients with myocardial ischaemia', but to evaluate the potential of magnesium for inhibiting the normal thermoregulatory defenses to hypothermia in humans. In this type of study, usually done in healthy volunteers, it is common to adopt an escalating dose scheme or high-dose infusion in order to adequately characterize the dose-response relationship and identify the magnitude of the effect for the agent under evaluation. In addition, since the central nervous system (CNS) is the major site for thermoregulatory effect and magnesium demonstrates a low CNS bioavailability, 6 a 'high-dose' approach was essential in the present experiment. Although various patient populations may respond differently to a particular agent or dosing strategy, it is worth noticing that the serum magnesium concentrations achieved in our study (1.89-2.21 mmol litre À1 ) were lower than those suggested for the treatment of eclampsia (2.0-4.0 mmol litre À1 ) 7 and much lower than those producing respiratory (5.0-6.5 mmol litre À1 ) or cardiac (>7.5 mmol litre À1 ) toxicity. 8 Interestingly, similar serum magnesium target concentrations (1-2 mmol litre À1 ) are currently used in clinical trials evaluating the neuroprotective properties of the agent in patients with subarachnoidal haemorrhage.
10
Because of the excellent neuroprotective record of magnesium in animals, a corollary of our investigation is the potential use of magnesium to facilitate the application of therapeutic hypothermia 11 in patients who suffer from neurological or myocardial ischemic injury. We have managed to exclude the possibility of magnesium use, as a sole agent, for that purpose. Nonetheless, a window remains open for the potential supplementary role of the agent to facilitate induced hypothermia. We certainly recognize the diverse and potentially serious complications of i.v. magnesium administration in sick patients. However, the range of dose and method of administration, as well as potential viable combinations with other agents are the objectives of ongoing and future trials in volunteers and various patient populations. There did not seem to be any pre-intervention testing. This means that the tendency in the simulator group to use DC cardioversion for the patient with ventricular tachycardia (VT) could have been present at baseline. These are third year students and it is not inconceivable that they could have some knowledge about the treatment of VT from their previous years of medical school. Additionally, this teaching was incorporated as part of a 6-week course, and the authors do not state when during this time the seminars were given. If the students taught with the simulator received their teaching nearer the end of their course than the control group, it would not be surprising if they performed better when tested. Moreover, a repeat test at 3-6 months may help to determine whether the perceived gain in the simulator group is sustained, particularly as skills learnt using simulators are often not retained long term.
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There were two statistically significant findings relating to the students' views of the seminars. Firstly, those receiving teaching with the simulator felt that the seminar was better at linking theory to practice as has been demonstrated previously.
3 Although the difference reached statistical significance, even the control group agreed that the course was good at linking theory to practice. Secondly, the simulator group was less likely to think that the course contained too much theory. It is not surprising that students were more positive about a seminar including just 45 min of PowerPoint presentations followed by a session with a simulator compared with a seminar containing 2 h of PowerPoint presentations! A similar positive effect may have been seen if a third group had been studied that was exposed to a more entertaining teaching method than PowerPoint lectures; for example, videos of 'real life' patient treatment or computer-aided learning (CAL). There is evidence to suggest that simulators do not confer any greater educational value than videos 4 5 and CAL has been demonstrated to be an effective teaching aid for undergraduates.
6
The authors also talk enthusiastically about their interdisciplinary approach and how they believe that this led to the overall good results. Although it is an attractive suggestion that incorporating anaesthetists in interdisciplinary teaching improves students' learning experience, it could simply be the ability and enthusiasm of the teachers that was the reason for success and that their individual specializations made no difference. Mueller's paper does not provide evidence to support the idea that interdisciplinary teaching is more effective as there was no group which had single disciplinary teaching.
Simulators are fun to use but have limitations and are expensive. Costs that need to be considered include the initial cost of purchasing simulators, maintenance costs and the cost of training instructors. Studies have tried to show their effectiveness in teaching but most have concluded only that they are 'at least as effective' as other entertaining teaching methods. If expense is no problem, then simulators can be a useful teaching alternative, but more research is needed before their expense can be fully justified for teaching in this area. During the 6 week course 'Basics of Drug Therapy' one lecture is held on antiarrhythmic drugs. All students took part in our course 'Anthiarrhythmic Therapy and ECG' after that lecture, there are no additional lectures or seminars on antiarrhythmic drugs. To avoid a bias in pre-intervention knowledge between both groups, we randomized students into control and simulator group. A repeat test would have been helpful to evaluate long-term retention of knowledge on antiarrhythmic therapy but was not done. However, the treatment of arrhythmia is complex and cannot be compared with the retention of basic life support skills 2 as mentioned by Brown and Kessell. A previous study showed good retention of pharmacology knowledge in third year medical students. The study cited by Brown and Kessell which had previously shown good linking of theory and practice using simulators 3 cannot be compared with our study in this context. We would surely not expect the same results when investigating the use of a part task trainer in pharmacological Correspondence
